30 employees
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
2020
$24M
from 3 investors over 3 rounds
InnoSkel raised $24M on December 14, 2020
Investors: Région Sud Investissement, Vida Ventures, LLC and JEITO